Literature DB >> 1652470

The chloride channel blocker 5-nitro-2-(3-phenylpropyl-amino) benzoic acid (NPPB) uncouples mitochondria and increases the proton permeability of the plasma membrane in phagocytic cells.

G L Lukacs1, A Nanda, O D Rotstein, S Grinstein.   

Abstract

We present evidence that the potent chloride channel blocker NPPB has protonophoric activity in the mitochondria and across the plasma membrane of phagocytic cells. The resting O2 consumption of murine peritoneal macrophages was stimulated up to 2.5-fold in the presence of NPPB, with a K0.5 of 15 microM. The stimulatory effect of NPPB on O2 consumption, like that of the classical protonophore CCCP, was prevented by the mitochondrial respiratory chain inhibitors antimycin A, rotenone or cyanide. NPPB also mediated rheogenic proton transport across the plasma membrane of human neutrophils and macrophages in the direction dictated by the electrochemical proton gradient. As a consequence of its protonophoric activity, NPPB uncoupled mitochondrial ATP synthesis, resulting in partial depletion of cellular ATP. These observations indicate that, at the concentrations frequently used for blockade of anion channels, NPPB acts as an effective protonophore, potentially disturbing cytosolic pH and mitochondrial ATP synthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652470     DOI: 10.1016/0014-5793(91)80992-c

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Transmitter-induced changes of the membrane voltage of HT29 cells.

Authors:  E Lohrmann; Z I Cabantchik; R Greger
Journal:  Pflugers Arch       Date:  1992-06       Impact factor: 3.657

2.  Single-cell intracellular nano-pH probes.

Authors:  Rıfat Emrah Özel; Akshar Lohith; Wai Han Mak; Nader Pourmand
Journal:  RSC Adv       Date:  2015-06-09       Impact factor: 3.361

3.  Chloride channel blockers decrease intracellular pH in cultured renal epithelial LLC-PK1 cells.

Authors:  C D Brown; A J Dudley
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.

Authors:  Pingwei Zhao; Haleli Sharir; Ankur Kapur; Alan Cowan; Ellen B Geller; Martin W Adler; Herbert H Seltzman; Patricia H Reggio; Susanne Heynen-Genel; Michelle Sauer; Thomas D Y Chung; Yushi Bai; Wei Chen; Marc G Caron; Larry S Barak; Mary E Abood
Journal:  Mol Pharmacol       Date:  2010-07-22       Impact factor: 4.436

5.  Cell Cl and transepithelial na transport in toad urinary bladder.

Authors:  A G Butt; C W McLaughlin; J M Bowler; R D Purves; A D Macknight
Journal:  J Membr Biol       Date:  1994-10       Impact factor: 1.843

6.  cAMP-dependent activation of small-conductance Cl- channels in HT29 colon carcinoma cells.

Authors:  K Kunzelmann; M Grolik; R Kubitz; R Greger
Journal:  Pflugers Arch       Date:  1992-06       Impact factor: 3.657

7.  The outwardly rectifying Cl- channel is not involved in cAMP-mediated Cl- secretion in HT-29 cells: evidence for a very-low-conductance Cl- channel.

Authors:  H Fischer; K M Kreusel; B Illek; T E Machen; U Hegel; W Clauss
Journal:  Pflugers Arch       Date:  1992-11       Impact factor: 3.657

8.  Crypt base cells show forskolin-induced Cl- secretion but no cation inward conductance.

Authors:  D Ecke; M Bleich; R Greger
Journal:  Pflugers Arch       Date:  1996-01       Impact factor: 3.657

9.  Chloride channel blockers inhibit Ca2+ uptake by the smooth muscle sarcoplasmic reticulum.

Authors:  N S Pollock; M E Kargacin; G J Kargacin
Journal:  Biophys J       Date:  1998-10       Impact factor: 4.033

10.  Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation.

Authors:  S Denk; R P Taylor; R Wiegner; E M Cook; M A Lindorfer; K Pfeiffer; S Paschke; T Eiseler; M Weiss; E Barth; J D Lambris; M Kalbitz; T Martin; H Barth; D A C Messerer; F Gebhard; M S Huber-Lang
Journal:  Scand J Immunol       Date:  2017-09       Impact factor: 3.487

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.